Search
XNAS • Healthcare

enGene Therapeutics Inc. Common Stock (ENGN)

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · 4868 RUE LEVY, SUITE 220, SAINT-LAURENT

XNASstockActive listing
1.58
-0.09 (-5.39%)
Quote updated 10/19/2026, 4:00:00 AM
Previous close1.67
Open1.66
Day range1.58 – 1.70
52-week range1.40 – 12.25
Volume783,845
Market cap115.94M
PRICE HISTORY

Stock price history and performance

Daily closing prices from the stored market history.

250 sessions
$13$10$7$4$1Oct 21Apr 21Oct 19
STOCK RESEARCH · EDITORIAL ANALYSIS

enGene Therapeutics Inc. Common Stock (ENGN): Investment Research & Business Outlook

A research-led explanation of the company, its financial evidence, valuation context and risks—not just a list of market numbers.

Research note

What the available evidence tells us

The latest stored quote for enGene Therapeutics Inc. Common Stock (ENGN) is 1.58, timestamped 10/19/2026, 4:00:00 AM. A quote is a point-in-time observation; it does not, by itself, explain why the price moved or establish whether the shares are attractive.

Business and financial quality

enGene Therapeutics Inc is a clinical-stage biotechnology company mainstreaming gene therapy through the delivery of therapeutics to mucosal tissues and other organs, to create new ways to address diseases with high clinical needs. Its pioneering program is detalimogene voraplasmid (also known as detalimogene) for patients with Non-Muscle Invasive Bladder Cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase 2 trial, which includes a pivotal cohort studying detalimogene in high-risk, Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (CIS) with or without concomitant papillary disease. It is developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX) platform. Stored fundamentals include 26 usable headline metrics. These should be read across several reporting periods and compared with peers before drawing a conclusion about business quality.

Valuation: context matters

The stored trailing P/E ratio is 2.1. P/E compares a company’s share price with its earnings, but it should be interpreted alongside expected growth, earnings quality, cyclicality and comparable companies.

Price trend and quantitative outlook

The chart is based on 250 stored daily price observations. Historical performance describes what happened over that period; it is not a guarantee of future returns. The current stored quantitative model signal is “neutral”. Treat model outputs as scenarios with uncertainty, not as certain targets or personalized advice.

Key risks and what to watch next

Risk records exist for this company; review the risk and performance section below for the available volatility, drawdown and risk-adjusted measures. The next useful evidence to review is the company’s next reported financial results, changes in forward estimates, and primary-source disclosures.

Editorial integrity: this summary uses fields available in the current database. Missing evidence is called out rather than filled with invented facts.

What the numbers mean for investors

Business quality

A reliable revenue-growth reading is not available or is not positive in the latest stored snapshot. Review multiple reporting periods before judging the growth trajectory.

Profitability

Margin data is incomplete. Revenue alone cannot show whether the company converts sales into sustainable profit.

Valuation

The stored P/E is 2.1. A multiple is not a verdict by itself: interpret it alongside expected earnings growth, cyclicality, cash flow, and comparable companies.

Price trend

The latest quote can be compared with the 20-, 50- and 200-day moving averages (1.83, 1.83, and 4.68). Moving averages describe trend, not intrinsic value, and can lag sudden market changes.

Bull case, bear case and evidence to watch

Bull case

The bullish case needs confirmation from reported revenue growth, cash generation, and future company disclosures; the current snapshot does not establish those conditions together.

Bear case

Potential downside still includes weaker demand, margin compression, competition, execution issues, or a broad market sell-off. Company-specific evidence is needed to quantify these risks.

What to watch next

Track the next earnings release, changes in revenue and margin trends, cash flow, management guidance, analyst estimate revisions, and primary-source filings. Update the thesis when new evidence arrives rather than relying on one ratio or forecast.

These interpretations are rule-based explanations of the stored fields, not independently verified company-specific forecasts. Missing data is not treated as zero; all investment cases remain conditional on new evidence.

US Market AI Research Desk · Data/research timestamp: Oct 19, 2026 · Methodology & disclaimer
QUANTITATIVE RESEARCH

Stock forecast and analysis: price outlook

Forecasts are model outputs, not promises or personalized investment advice.

neutral
HorizonModel targetExpected changeSignalConfidence score
24H1.56-1.30%neutral82
7D1.50-4.89%bearish82
30D1.37-13.11%bearish82
90D1.19-25.00%bearish82

Long-term model scenarios

Latest stored scenario per future target year. Bear, base and bull prices are model scenarios, not guaranteed targets. The relative model score is not a calibrated probability; uncertainty rises materially for distant years.

Target yearBase caseBear caseBull caseExpected CAGRRelative model scoreSignal
20271.771.771.771.35%67long-term-neutral
20301.901.861.952.18%66long-term-positive
20352.282.092.493.03%65long-term-positive
20402.822.383.333.48%62long-term-positive
20504.323.105.993.85%58long-term-positive
COMPANY FUNDAMENTALS

Financial performance and company fundamentals

Reported fields from the current fundamentals snapshot.

Revenue0Total sales reported for the period; compare growth across several periods.
Gross profit0Interpret alongside the company’s history, sector peers, reporting period and data source.
Operating income-31.97MInterpret alongside the company’s history, sector peers, reporting period and data source.
Net income-30.23MInterpret alongside the company’s history, sector peers, reporting period and data source.
EPS (reported period)-0.43Earnings per share for the stored reporting period; confirm whether the figure is quarterly, annual or trailing twelve months before comparing it with valuation multiples.
EPS growth-15.69%Interpret alongside the company’s history, sector peers, reporting period and data source.
EBITDA-62.78MInterpret alongside the company’s history, sector peers, reporting period and data source.
EBIT-31.97MInterpret alongside the company’s history, sector peers, reporting period and data source.
Cash & equivalents29.83MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total assets307.52MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total liabilities52.36MInterpret alongside the company’s history, sector peers, reporting period and data source.
Total debt0Interpret alongside the company’s history, sector peers, reporting period and data source.
Shareholders equity255.17MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current assets270MInterpret alongside the company’s history, sector peers, reporting period and data source.
Current liabilities21.49MInterpret alongside the company’s history, sector peers, reporting period and data source.
Operating cash flow-30.5MInterpret alongside the company’s history, sector peers, reporting period and data source.
Capital expenditure98KInterpret alongside the company’s history, sector peers, reporting period and data source.
Free cash flow-30.6MCash remaining after operating needs and capital expenditure; can support investment or shareholder returns.
Return on equity-11.85%Profit generated relative to book equity; leverage and one-off gains can distort it.
Return on assets-9.83%Interpret alongside the company’s history, sector peers, reporting period and data source.
Debt / equity0Debt relative to shareholder equity; definitions may vary by data provider.
Price / book0.49Interpret alongside the company’s history, sector peers, reporting period and data source.
Earnings yield+47.51%Interpret alongside the company’s history, sector peers, reporting period and data source.
Shares outstanding69,724,761Interpret alongside the company’s history, sector peers, reporting period and data source.
Book value / share3.66Interpret alongside the company’s history, sector peers, reporting period and data source.
FCF / share-0.44Interpret alongside the company’s history, sector peers, reporting period and data source.
Market cap115.94MMarket value of outstanding shares, not the same as enterprise value.
P/E ratio2.1Share price relative to earnings per share; interpret alongside growth and peers.
52-week high12.25Highest stored price over the rolling year; not a fair-value estimate.
52-week low1.40Lowest stored price over the rolling year; not a support guarantee.
Average volume783,845Typical shares traded; helps assess liquidity but can change around events.
TECHNICALS

Technical indicators

Latest stored daily indicator snapshot; unavailable indicators are omitted.

Oct 20, 2026
RSI (14)35.8Momentum oscillator from 0–100; extreme readings are context, not automatic buy/sell signals.
SMA 201.83Average closing price over about 20 trading sessions; a short-term trend reference.
SMA 501.83Average closing price over about 50 sessions; often used to assess medium-term direction.
SMA 1001.81Interpret alongside the company’s history, sector peers, reporting period and data source.
SMA 2004.68Average closing price over about 200 sessions; a longer-term trend reference.
EMA 201.77Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 501.87Interpret alongside the company’s history, sector peers, reporting period and data source.
EMA 2004.00Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD-0.07Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD signal-0.04Interpret alongside the company’s history, sector peers, reporting period and data source.
MACD histogram-0.03Difference between MACD and its signal line; sign and changes indicate momentum shifts.
Bollinger upper2.13Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger middle1.83Interpret alongside the company’s history, sector peers, reporting period and data source.
Bollinger lower1.53Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic4.35Interpret alongside the company’s history, sector peers, reporting period and data source.
Stochastic signal20.289855072463755Interpret alongside the company’s history, sector peers, reporting period and data source.
Williams %R-95.65Interpret alongside the company’s history, sector peers, reporting period and data source.
CCI-109.86Interpret alongside the company’s history, sector peers, reporting period and data source.
MFI32.93Interpret alongside the company’s history, sector peers, reporting period and data source.
ROC-20.20%Interpret alongside the company’s history, sector peers, reporting period and data source.
OBV13.29MInterpret alongside the company’s history, sector peers, reporting period and data source.
Momentum-15.51Interpret alongside the company’s history, sector peers, reporting period and data source.
Volatility+56.53%Interpret alongside the company’s history, sector peers, reporting period and data source.
ATR0.1Average true range estimates recent price movement size, not direction.
ADX40.9Measures trend strength, not whether the trend is bullish or bearish.
Support level1.56Interpret alongside the company’s history, sector peers, reporting period and data source.
Resistance level2.08Interpret alongside the company’s history, sector peers, reporting period and data source.
TrendbearishInterpret alongside the company’s history, sector peers, reporting period and data source.
REPORTED RESULTS

Financial statements, earnings history and estimate revisions

Recent normalized financial statement records.

Showing up to 60 recent statement records. Reported periods and statement types are preserved; blank values are not estimated. Contradictory zero sentinels are withheld instead of presented as verified facts.

PeriodStatementFiscal periodBasisRevenueCost of revenueGross profitOperating incomeNet incomeBasic EPSDiluted EPSCashTotal assetsTotal liabilitiesDebtEquityOperating cash flowCapexFree cash flowSource
Apr 30, 2026balance sheetFY-2026-Q2quarterly———————29.83M307.52M52.36M0255.17M———3spread
Apr 30, 2026cash flowFY-2026-Q2annual————————————-59.4M251K-59.65M3spread
Apr 30, 2026cash flowFY-2026-Q2quarterly————————————-30.5M98K-30.6M3spread
Apr 30, 2026income statementFY-2026-Q2annual000-63.15M-59.98M-0.88-0.88————————3spread
Apr 30, 2026income statementFY-2026-Q2quarterly0—0-31.97M-30.23M-0.43-0.43————————3spread
Jan 31, 2026balance sheetFY-2026-Q1quarterly———————36.61M337.11M55.57M0281.55M———3spread
Jan 31, 2026cash flowFY-2026-Q1quarterly————————————-28.9M153K-29.06M3spread
Jan 31, 2026income statementFY-2026-Q1quarterly0—0-31.19M-29.75M0.440.44————————3spread
Oct 31, 2025balance sheetFY-2025-Q4quarterly———————50.15M221.47M53.76M0167.71M———3spread
Oct 31, 2025cash flowFY-2025-Q4annual————————————-99.24M1.49M-100.72M3spread
Oct 31, 2025cash flowFY-2025-Q4quarterly————————————-24.96M437K-25.4M3spread
Oct 31, 2025income statementFY-2025-Q4quarterly0—0-39.48M-37.88M-0.74-0.74————————3spread
Oct 31, 2025income statementFY-2025-Q4annual0—0-123.17M-117.3M2.292.29————————3spread
Jul 31, 2025balance sheetFY-2025-Q3quarterly———————32.62M245.55M44.88M0200.67M———3spread
Jul 31, 2025cash flowFY-2025-Q3quarterly————————————-74.28M1.05M-75.33M3spread
Jul 31, 2025income statementFY-2025-Q3quarterly0—0-29.95M-28.99M0.570.57————————3spread
Apr 30, 2025balance sheetFY-2025-Q2quarterly———————57.55M266.65M39.36M0227.29M———3spread
Apr 30, 2025cash flowFY-2025-Q2quarterly————————————-22.95M45K-22.99M3spread
Apr 30, 2025cash flowFY-2025-Q2annual————————————-48.64M344K-48.99M3spread
Apr 30, 2025income statementFY-2025-Q2annual0—0-53.74M-50.43M-0.99-0.99————————3spread
Apr 30, 2025income statementFY-2025-Q2quarterly0—0-27.12M-25.82M-0.51-0.51————————3spread
Jan 31, 2025balance sheetFY-2025-Q1quarterly———————62.35M285.93M35.98M0249.95M———3spread
Jan 31, 2025cash flowFY-2025-Q1quarterly————————————-25.7M299K-26M3spread
Jan 31, 2025income statementFY-2025-Q1quarterly0—0-26.61M-24.62M0.480.48————————3spread
Oct 31, 2024balance sheetFY-2024-Q4quarterly———————173M311.17M38.56M0272.61M———3spread
Oct 31, 2024cash flowFY-2024-Q4quarterly————————————-19.57M238K-19.81M3spread
Oct 31, 2024cash flowFY-2024-Q4annual————————————-48.28M925K-49.21M3spread
Oct 31, 2024income statementFY-2024-Q4quarterly0—0-17.46M-15.3M-0.40-0.40————————3spread
Oct 31, 2024income statementFY-2024-Q4annual0—0-62.3M-55.14M1.461.46————————3spread
Jul 31, 2024balance sheetFY-2024-Q3quarterly———————257.68M266.88M36.55M0230.33M———3spread
Jul 31, 2024cash flowFY-2024-Q3quarterly————————————-28.71M687K-29.4M3spread
Jul 31, 2024income statementFY-2024-Q3quarterly0—0-16.76M-14.15M0.320.32————————3spread
Apr 30, 2024balance sheetFY-2024-Q2quarterly———————264.81M273.53M30.56M0242.97M———3spread
Apr 30, 2024cash flowFY-2024-Q2annual————————————-21.53M685K-22.22M3spread
Apr 30, 2024cash flowFY-2024-Q2quarterly————————————-14.16M179K-14.34M3spread
Apr 30, 2024income statementFY-2024-Q2annual0—0-28.08M-25.7M0.820.82————————3spread
Apr 30, 2024income statementFY-2024-Q2quarterly0—0-17.31M-14.98M0.380.38————————3spread
Jan 31, 2024balance sheetFY-2024-Q1quarterly———————85.65M93.42M31.04M062.39M———3spread
Jan 31, 2024cash flowFY-2024-Q1quarterly————————————-7.37M506K-7.88M3spread
Jan 31, 2024income statementFY-2024-Q1quarterly0—0-10.77M-10.71M0.460.46————————3spread
Oct 31, 2023balance sheetFY-2023-Q4quarterly———————81.52M86.96M14.47M072.49M———3spread
Oct 31, 2023cash flowFY-2023-Q4quarterly————————————-6.78M138K-6.91M3spread
Oct 31, 2023cash flowFY-2023-Q4annual————————————-24.74M318K-25.06M3spread
Oct 31, 2023income statementFY-2023-Q4annual0—0-26.06M-99.92M151.22151.22————————3spread
Oct 31, 2023income statementFY-2023-Q4quarterly0—0-10.44M-82.5M-120.69-120.69————————3spread
Jul 31, 2023cash flowFY-2023-Q3quarterly————————————-17.97M180K-18.15M3spread
Jul 31, 2023income statementFY-2023-Q3quarterly0—0-15.62M-17.42M30.7730.77————————3spread
Apr 30, 2023cash flowFY-2023-Q2annual————————————-10.67M23K-10.69M3spread
Apr 30, 2023income statementFY-2023-Q2quarterly0—0-4.74M-5.28M9.309.30————————3spread
Apr 30, 2023income statementFY-2023-Q2annual0—0-9.37M-12.7M22.1922.19————————3spread
Jan 31, 2023cash flowFY-2023-Q1quarterly————————————-6.22M13K-6.24M3spread
Jan 31, 2023income statementFY-2023-Q1quarterly0—0-4.63M-7.42M13.2913.29————————3spread
Oct 31, 2022balance sheetFY-2022-Q4quarterly———————20.43M23.91M47.41M0-23.5M———3spread
Oct 31, 2022cash flowFY-2022-Q4annual————————————-17.59M153K-17.75M3spread
Oct 31, 2022income statementFY-2022-Q4annual0—0-19.43M-24.46M44.3044.30————————3spread

Financial metric history

PeriodRevenue growthGross marginOperating marginNet marginROEROIC
Apr 30, 2026————-11.85%—

Earnings history

These are SEC-reported financial facts grouped by fiscal period. The displayed date is the SEC filing/observation date, not a verified earnings announcement or release date. Use the company’s investor-relations calendar for confirmed earnings-release timing.

SEC filing / observation dateFiscal periodEPS reportedEPS estimateRevenue reportedRevenue estimate
Sep 8, 2026Q3-0.47———
Jun 15, 2026Q2-0.43———
Mar 9, 2026Q10.44———
Dec 22, 2025FY2.29———
Sep 11, 2025Q30.57———
Jun 12, 2025Q20.51———
VALUATION

Stock valuation: P/E, forward P/E and multiples

Multiples shown only when the database has a usable value.

P/E ratio2.1
Price / book0.49
Enterprise value90.8M

Peer comparisons are withheld until a comparable industry group and a reliable peer set are verified.

LATEST DEVELOPMENTS

News and company updates

Stories linked to this stock in the current database.

SHAREHOLDER RETURNS

Dividend data and payment history

Source-specific dividend records, with unavailable event dates left blank.

These are SEC-reported dividends-per-share facts. The stored date is the SEC filing/observation date, not a confirmed declaration or ex-dividend date. These records do not establish record dates or payment dates and must not be treated as a dividend payment calendar.

SEC filing / observation dateReported dividend per shareCurrencySource
Sep 8, 20260.0000USDSEC_XBRL_BULK
Jun 15, 20260.0000USDSEC_XBRL_BULK
Mar 9, 20260.0000USDSEC_XBRL_BULK
Dec 22, 20250.0000USDSEC_XBRL_BULK
Sep 11, 20250.0000USDSEC_XBRL_BULK
Jun 12, 20250.0000USDSEC_XBRL_BULK
Mar 10, 20250.0000USDSEC_XBRL_BULK
Dec 19, 20240.0000USDSEC_XBRL_BULK
Jan 29, 20240.0000USDSEC_XBRL_BULK
RISK CONTEXT

Risk and performance profile

Computed risk/performance records; not a recommendation. Mathematically uninterpretable or extreme ratios are withheld rather than displayed as reliable facts.

Volatility+40.83%
Beta2.05
ATR0.09
Maximum drawdown-88.17%
Sharpe ratio-0.22
Sortino ratio-0.2
Debt / equity0
Current ratio12.57
Interest coverage-42.76
1-day return-2.81%
5-day return-10.05%
1-month return-4.12%
3-month return-8.64%
6-month return-75.90%
YTD return-80.68%
1-year return-77.04%
All-time return-59.42%
RESEARCH EVIDENCE

Source data and research records

Expandable evidence tables keep the main page focused while preserving detailed data.

Institutional holders and ownership

Showing up to 50 recent holder records. Values failing a basic implied-price check are withheld, not silently corrected.

PeriodFiledHolderCIKSharesValueOwnershipShares changeChange %Source
Jun 30, 2026Aug 14, 2026Nextech Invest Ltd.15954302,324,9434.02M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Rangeley Capital, LLC1517796305,102527.83K———SEC_13F_DATASET
Jun 30, 2026Aug 11, 2026Blue Owl Capital Holdings LP1858703511,177148.19K———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026SIMPLEX TRADING, LLC148854244,20076.47K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026BNP PARIBAS FINANCIAL MARKETS116658825,41943.98K———SEC_13F_DATASET
Jun 30, 2026Jul 27, 2026Peapod Lane Capital LLC20509791,102,1491.91M———SEC_13F_DATASET
Jun 30, 2026Jul 9, 2026Marquette Asset Management, LLC1395067150,546260.45K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Affinity Asset Advisors, LLC1773195600,0001.04M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026AMERIPRISE FINANCIAL INC8200272,675,8764.63M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026HRT FINANCIAL LP147559716,831Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Elmind Capital, LP2052213210,000363.3K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026BARCLAYS PLC312069282,515488.75K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026PERCEPTIVE ADVISORS LLC12249624,822,1698.34M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026CSS LLC/IL110364616,8954.9K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026ROYAL BANK OF CANADA10002757,91514K———SEC_13F_DATASET
Jun 30, 2026Aug 17, 2026Seven Fleet Capital Management LP2092021411,065711.14K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026TORONTO DOMINION BANK94726310029———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026LMR Partners LLP1578621309,76389.8K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026Privium Fund Management B.V.1795097170,000294.1K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Caption Management, LLC1706766333,67596.73K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026TWO SIGMA INVESTMENTS, LP1179392164,570284.71K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Qube Research & Technologies Ltd1729829200,187346.32K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026ARISTEIA CAPITAL, L.L.C.1080171197,67847.67K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026Quadrature Capital Ltd1651424239,035413.53K———SEC_13F_DATASET
Jun 30, 2026Aug 10, 2026WOLVERINE ASSET MANAGEMENT LLC12798912,9645.13K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SECTORAL ASSET MANAGEMENT INC127441321,70037.54K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026Virtu Financial LLC153396413,986Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SEI INVESTMENTS CO35089418,50432.01K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026GROUP ONE TRADING LLC93254016,50028.55K———SEC_13F_DATASET
Jun 30, 2026Jul 20, 2026PFS Partners, LLC200265411,00019.03K———SEC_13F_DATASET
Jun 30, 2026Aug 6, 2026GSA CAPITAL PARTNERS LLP136203337,346Withheld: value fails validation———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026JANE STREET GROUP, LLC1595888217,628376.5K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP1446194313,100541.66K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026Persistent Asset Partners Ltd2056052114,493198.07K———SEC_13F_DATASET
Jun 30, 2026Aug 13, 2026MORGAN STANLEY8954213,3305.76K———SEC_13F_DATASET
Jun 30, 2026Aug 12, 2026Clear Street Group Inc.188156720058———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Vestal Point Capital, LP19749151,667,4302.88M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026BVF INC/IL1056807945,402274.07K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Balyasny Asset Management L.P.12187101,007,3441.74M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Aquatic Capital Management LLC18039162950———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026WELLS FARGO & COMPANY/MN729716,84011.83K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026KENNEDY CAPITAL MANAGEMENT LLC884589268,735464.91K———SEC_13F_DATASET
Jun 30, 2026Aug 7, 2026BML Capital Management, LLC16168246,669,90811.54M———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Engineers Gate Manager LP162022027,28647.21K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026RAYMOND JAMES FINANCIAL INC72000521,35636.95K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026XTX Topco Ltd1828301151,424261.96K———SEC_13F_DATASET
Jun 30, 2026Jul 23, 2026SBI Securities Co., Ltd.18518152848———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Woodline Partners LP1784547250,000432.5K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Kynam Capital Management, LP1907884457,855792.09K———SEC_13F_DATASET
Jun 30, 2026Aug 14, 2026Jain Global LLC202457943,23174.79K———SEC_13F_DATASET
PeriodShares outstandingInstitutional ownershipInsider ownership
Jun 30, 202669,724,761+57.08%+0.01%
Insider transactions

Reported transaction values and remaining holdings are shown only when supplied by the source.

Transaction dateFiledInsiderTitleTypeCodeSharesPriceReported valueShares afterFilingSource
Sep 22, 2026Sep 24, 2026Grossman WilliamInterim Chief Medical OfficerPurchaseP5,1021.9710.05K5,102Open filingSEC_FORM_3_4_5
SEC filings

Showing up to 30 latest filings. Open the original SEC document when a URL is available.

FiledAcceptedFormDescriptionReporting periodAccessionSEC document
Sep 24, 2026—4—Sep 22, 20260001552781-26-000501View filing
Sep 8, 2026—10-Q10-QJul 31, 20260001193125-26-384383View filing
Sep 8, 2026—8-K8-KSep 8, 20260001193125-26-384380View filing
Aug 11, 2026—8-K8-KAug 11, 20260001193125-26-344559View filing
Jul 22, 2026—3—Jul 16, 20260000929638-26-002666View filing
Jul 22, 2026—3—Jul 16, 20260000929638-26-002667View filing
Jul 17, 2026—8-K8-KJul 17, 20260001193125-26-307795View filing
Jul 16, 2026—8-K8-KJul 15, 20260001193125-26-305418View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002262View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002261View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002260View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002259View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002258View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002263View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002257View filing
Jun 17, 2026—4—Jun 16, 20260000929638-26-002256View filing
Jun 15, 2026—8-K8-KJun 13, 20260001193125-26-270384View filing
Jun 15, 2026—10-Q10-QApr 30, 20260001193125-26-270386View filing
Jun 10, 2026—8-K8-KJun 9, 20260001193125-26-265830View filing
May 8, 2026—DEF 14ADEF 14AJun 9, 20260001140361-26-020024View filing
May 7, 2026—8-K8-KMay 5, 20260001193125-26-210316View filing
Apr 9, 2026—8-K8-KApr 7, 20260001193125-26-149597View filing
Mar 9, 2026—8-K8-KMar 9, 20260001193125-26-097546View filing
Mar 9, 2026—10-Q10-QJan 31, 20260001193125-26-097541View filing
Mar 9, 2026—8-K8-KMar 9, 20260001193125-26-097534View filing
Feb 19, 2026—S-3S-3—0001193125-26-059479View filing
Feb 3, 2026—4—Jan 30, 20260000929638-26-000482View filing
Feb 3, 2026—4—Jan 30, 20260000929638-26-000480View filing
Feb 3, 2026—4—Jan 30, 20260000929638-26-000483View filing
Feb 3, 2026—4—Jan 30, 20260000929638-26-000479View filing
Quarterly and monthly research
PeriodResearch summary
Apr 30, 2026Derived quarterly snapshot; AI narrative pending
Apr 30, 2026Latest reported fundamentals for fiscal period FY-2026-Q2. Revenue: $0. EPS: $-0.430. EPS growth: -15.69%. Gross margin: NaN%. Operating margin: -Infinity%. Net margin: -Infinity%. Free cash flow: $-30596000.
MonthResearch summary
Oct 1, 2026Derived monthly snapshot; AI narrative pending
Third-party metrics and ratios

Showing up to 40 recent metric records and 40 ratio records from the query window. Provider periods, units and validity flags are preserved when available.

PeriodReport periodFiscal yearQuarterPeriod typeCategoryValueUnitCurrencyValidSource
Apr 30, 2026Apr 30, 202620262semiannualtotal_other_income_expense3,174,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_liabilities52,356,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_liab_equity307,524,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualtotal_expenses-63,153,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_equity255,168,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_debt25,103,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_current_liabilities21,485,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_current_assets270,000,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_common_equity255,168,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instanttotal_assets307,524,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualstock_based_compensation6,948,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantshort_term_investments228,713,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualshares_diluted68,473,598sharesUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualshares_basic68,473,598sharesUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantretained_earnings-432,011,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualrepayments_of_long_term_debt-23,053,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualpurchases_of_investments-219,401,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyproceeds_from_stock_issuance4,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyproceeds_from_sales_and_maturities_of_investments73,950,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyproceeds_from_long_term_debt0USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantprepaid_and_other_assets_combined10,638,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlypayment_of_debt_issuance_costs70,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantother_receivables822,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualother_non_operating_income-264,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualgeneral_and_administrative-18,703,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualresearch_and_development-44,450,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyfx_effect0—USDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualimpairment_charges147,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyinterest_paid456,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyother_operating_activities-523,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262semiannualstock_issuance_costs-9,448,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262instantcommon_stock631,995,000—USDYes3Spread
Apr 30, 2026Apr 30, 202620262instantaccounts_payable1,793,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantaccrued_expenses17,212,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantaccumulated_other_comprehensive_income-1,141,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantadditional_paid_in_capital56,325,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyamortization_of_debt_costs136,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlycapital_expenditures-98,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262instantcash_and_equivalents29,827,000USDUSDYes3Spread
Apr 30, 2026Apr 30, 202620262quarterlycash_beginning_of_period36,613,000USDUSDYes3Spread
PeriodReport periodFiscal yearQuarterPeriod typeRatio categoryRatioValuePercentileMissing inputsValidSource
Apr 30, 2026Apr 30, 202620262quarterlysectorebitda_margin_pct0+0.00%revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyefficiencyasset_turnover0+0.00%revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlycash_flowcf_margin_pct0+0.00%revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyprofitabilitygross_margin_pct0+0.00%gross_profit,revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyprofitabilitynet_margin_pct0+0.00%revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyprofitabilityoperating_margin_pct0+0.00%revenueNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyefficiencyreceivables_turnover0+0.00%revenue,receivablesNo3Spread
Apr 30, 2026Apr 30, 202620262quarterlyleverageinterest_coverage-42.91+7.95%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyleverageequity_multiplier1.21+20.85%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlysectordebt_to_ebitda-1.65+21.89%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyleveragedebt_to_equity0.21+20.24%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyliquiditycash_ratio1.39+88.50%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlycash_flowcf_to_net_income1.01+47.13%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyliquiditycurrent_ratio12.57+97.91%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyleveragedebt_to_assets0.17+6.43%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlycash_flowfree_cash_flow-30,596,000+14.19%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlycash_flowoperating_cf_ratio-1.42+1.75%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyliquidityquick_ratio12.57+97.91%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyprofitabilityroa_pct-9.83+7.63%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyprofitabilityroe_pct-11.85+7.36%—Yes3Spread
Apr 30, 2026Apr 30, 202620262quarterlyliquidityworking_capital248,515,000+47.74%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyefficiencyasset_turnover0+0.00%revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlycash_flowcf_margin_pct0+0.00%revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlysectorebitda_margin_pct0+0.00%revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyprofitabilitygross_margin_pct0+0.00%gross_profit,revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyefficiencyinventory_turnover0+0.00%cost_of_revenue,inventoryNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyprofitabilitynet_margin_pct0+0.00%revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyprofitabilityoperating_margin_pct0+0.00%revenueNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyefficiencyreceivables_turnover0+0.00%revenue,receivablesNo3Spread
Jan 31, 2026Jan 31, 202620261quarterlyliquiditycash_ratio1.49+92.23%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlycash_flowcf_to_net_income0.97+43.69%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyliquiditycurrent_ratio11.75+100.00%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyleveragedebt_to_assets0.16+5.68%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlysectordebt_to_ebitda-1.79+11.54%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyleveragedebt_to_equity0.2+11.49%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyleverageequity_multiplier1.2+16.50%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlycash_flowfree_cash_flow-29,056,000+9.52%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlyleverageinterest_coverage-42.6+5.26%—Yes3Spread
Jan 31, 2026Jan 31, 202620261quarterlycash_flowoperating_cf_ratio-1.17+0.00%—Yes3Spread
Data quality and provenance

This page does not fill gaps with sample data. Values shown above come from the connected market-data and research tables.

No verified records available for this section yet.
RetrievedDatasetProviderStatus
Oct 8, 2026company_profileUS Market AI / SEC-mapped universeVerified
Identifiers and model evaluation
IdentifierValueSource
cik1980845stocks.cik
tickerENGNstocks.symbol
No verified records available for this section yet.
QUICK ANSWERS

Frequently asked questions

What is ENGN stock's current price?

The latest stored quote for ENGN is 1.58. The quote timestamp is 10/19/2026, 4:00:00 AM. Prices can change during market hours.

What is the ENGN stock forecast and analysis?

The latest available quantitative model signal is “neutral”. Review the forecast horizons alongside the company's reported financials, valuation, technical indicators and risks below; model outputs are estimates, not guarantees or personalized investment advice.

What is the ENGN stock price target?

The forecast table shows stored quantitative model outputs for the available horizons. These are model targets, not necessarily Wall Street analyst consensus; a verified consensus target is not assumed unless explicitly stored.

What is the ENGN stock price prediction for 2030?

A stored long-term model scenario for 2030 is shown in the forecast table. Long-range scenarios are highly uncertain and should be reviewed alongside the model version and assumptions.

What are the bullish and bearish views on ENGN?

A sufficiently detailed analyst-opinion dataset is not currently stored for this stock. The bull and bear cases on this page are conditional evidence-based scenarios, not attributed analyst recommendations.

What is the ENGN stock price prediction for 2026?

A verified 2026 long-term model output is not currently stored for this stock. Check the forecast section for available horizons rather than relying on an unsupported target.

Is ENGN stock overvalued or undervalued?

The latest stored trailing P/E is 2.1. Those multiples alone cannot establish fair value; compare growth, cash flow, earnings quality, risk and relevant peers.

What is ENGN's P/E ratio?

The latest stored trailing P/E ratio is 2.1. P/E compares share price with earnings per share and should be interpreted alongside growth, cyclicality and accounting quality.

What is ENGN's 52-week high and low?

The stored 52-week range is 1.40 to 12.25. This describes the recent trading range, not a forecast or a guaranteed support/resistance level.

Does ENGN pay a dividend, and what is its dividend history?

The database contains 9 SEC-reported dividends-per-share fact record(s). These do not confirm an ex-dividend date, record date or payment date and are not a payment calendar.

When is ENGN's next earnings report?

The latest SEC filing/observation date in this database is Sep 8, 2026. This is not a verified earnings announcement date or a confirmed next-report date; check company investor relations for the official calendar.

How has ENGN stock performed recently?

The price chart uses 250 stored daily observations, and the market snapshot includes the latest available quote. Use the chart to inspect the period shown; past performance does not predict future returns.

Is ENGN stock in a bullish or bearish trend?

The stored technical snapshot classifies the trend as “bearish”. This rule-based label is based on available indicators and is not a standalone buy or sell signal.

What are the main risks of investing in ENGN?

Available risk metrics are shown in the risk and performance section. These metrics do not capture every business, competitive, regulatory or market risk; review company filings and disclosures as well.

Where can I find ENGN's financial statements and earnings history?

Use the Financial Statements section for stored statement records, financial metric history, earnings results and estimate revisions. Coverage depends on the data available for this company.

Does US Market AI provide a guaranteed ENGN price target?

No. Forecasts shown here are quantitative model outputs, not guarantees or personalized financial advice. Missing forecast values are left unavailable rather than filled with invented targets.

KEEP EXPLORING

Related Healthcare stocks

Other active stocks in this sector. This is a directory, not a performance ranking.

Browse all stocks ↗
LLYEli Lilly & Co.Healthcare1.05T market capJNJJohnson & JohnsonHealthcare630.04B market capABBVABBVIE INC.Healthcare483B market capMRKMerck & Co., Inc.Healthcare359.22B market cap
US MARKET AI · STOCK RESEARCH

Data availability varies by company and provider. Missing values are omitted rather than estimated. Forecasts are model outputs and should be independently evaluated.

Research updated Oct 19, 2026 · Research methodology · Disclaimer